» Articles » PMID: 10602467

Multiple Mutations Contribute to the Oncogenicity of the Retroviral Oncoprotein V-Rel

Overview
Journal Oncogene
Date 1999 Dec 22
PMID 10602467
Citations 54
Authors
Affiliations
Soon will be listed here.
Abstract

The avian Rev-T retrovirus encodes the v-Rel oncoprotein, which is a member of the Rel/NF-kappaB transcription factor family. v-Rel induces a rapidly fatal lymphoma/leukemia in young birds, and v-Rel can transform and immortalize a variety of avian cell types in vitro. Although Rel/NF-kappaB transcription factors have been associated with oncogenesis in mammals, v-Rel is the only member of this family that is frankly oncogenic in animal model systems. The potent oncogenicity of v-Rel is the consequence of a number of mutations that have altered its activity and regulation: for example, certain mutations decrease its ability to be regulated by IkappaBalpha, change its DNA-binding site specificity, and endow it with new transactivation properties. The study of v-Rel will continue to increase our knowledge of how cellular Rel proteins contribute to oncogenesis by affecting cell growth, altering cell-cycle regulation, and blocking apoptosis. This review will discuss biological and molecular activities of v-Rel, with particular attention to how these activities relate to structure - function aspects of the Rel/NF-kappaB transcription factors.

Citing Articles

YTHDC1 Mitigates Apoptosis in Bone Marrow Mesenchymal Stem Cells by Inhibiting and Augmenting Cardiac Function Following Myocardial Infarction.

Han W, Xiong W, Sun W, Liu W, Zhang Y, Li C Cell Transplant. 2024; 33:9636897241290910.

PMID: 39466658 PMC: 11528794. DOI: 10.1177/09636897241290910.


Overexpression of TRIM44 mediates the NF-κB pathway to promote the progression of ovarian cancer.

Yu Y, Li S, Sun J, Wang Y, Xie L, Guo Y Genes Genomics. 2024; 46(6):689-699.

PMID: 38691326 DOI: 10.1007/s13258-024-01517-7.


Mutations in the Vicinity of the IRAK3 Guanylate Cyclase Center Impact Its Subcellular Localization and Ability to Modulate Inflammatory Signaling in Immortalized Cell Lines.

Turek I, Nguyen T, Galea C, Abad I, Freihat L, Manallack D Int J Mol Sci. 2023; 24(10).

PMID: 37239919 PMC: 10217915. DOI: 10.3390/ijms24108572.


Biological and Exploitable Crossroads for the Immune Response in Cancer and COVID-19.

Vitali L, Merlini A, Galvagno F, Proment A, Sangiolo D Biomedicines. 2022; 10(10).

PMID: 36289890 PMC: 9599827. DOI: 10.3390/biomedicines10102628.


NF-κB and Human Cancer: What Have We Learned over the Past 35 Years?.

Gilmore T Biomedicines. 2021; 9(8).

PMID: 34440093 PMC: 8389606. DOI: 10.3390/biomedicines9080889.